Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Aug 08, 2003

Schwarz Pharma's KUDCo Not Seeking to Temporarily Halt Mylan's Omeprazole Sales

Aug 04, 2003

Mylan Announces Omeprazole Launch

Jul 23, 2003

Mylan Reports Record EPS, Revenues and Net Earnings for the First Quarter of Fiscal 2004 and Increases Annual Earnings Guidance

Jul 14, 2003

Mylan Announces First Quarter Fiscal 2004 Earnings Release Date and Conference Call

Jul 10, 2003

Mylan's Apomorphine NDA Advances in FDA Review Process

Jun 19, 2003

Mylan Acknowledges FDA Letter, Which Will Not Impact the Commercial Status of Amnesteem

Jun 19, 2003

Mylan Receives FDA Approval for Mirtazapine Tablets

Jun 16, 2003

Mylan Declares Regular Quarterly Cash Dividend

Jun 02, 2003

Mylan Announces Approval for Omeprazole Delayed-release Capsules

May 08, 2003

Mylan Reports Record EPS, Revenues and Net Earnings For the Fourth Quarter and Fiscal 2003

Pagination

First page
Previous page
…
Page 120
Page 121
Page 122
Page 123
Current page 124
Page 125
Page 126
Page 127
Page 128
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.